Private Trust Company’s VanEck Biotech ETF BBH Stock Holding History

Private Trust Company’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-102	Closed	-$16.5K	–	2288
2023 Q1	$16.5K	Buy	+102	New	+$16.5K	﹤0.01%	1403
2016 Q1	–	Sell	-2,511	Closed	-$318K	–	310
2015 Q4	$318K	Hold	2,511	–	–	0.09%	234
2015 Q3	$287K	Hold	2,511	–	–	0.09%	241
2015 Q2	$338K	Sell	2,511 -1,000	-28%	-$133K	0.1%	238
2015 Q1	$454K	Sell	3,511 -1,000	-22%	-$126K	0.13%	200
2014 Q4	$520K	Hold	4,511	–	–	0.16%	164
2014 Q3	$477K	Hold	4,511	–	–	0.16%	152
2014 Q2	$430K	Hold	4,511	–	–	0.14%	169
2014 Q1	$410K	Hold	4,511	–	–	0.15%	158
2013 Q4	$399K	Hold	4,511	–	–	0.16%	148
2013 Q3	$373K	Hold	4,511	–	–	0.17%	141
2013 Q2	$309K	Buy	+4,511	New	+$314K	0.14%	163

Other funds holding BBH

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Private Trust Company's BBH Position: Q2 2023 in Review

Private Trust Company sold out of VanEck Biotech ETF (BBH) in Q2 2023, closing a stake of 102 shares — an estimated $16.5K sold.

Private Trust Company first reported a position in BBH in Q2 2013 and held it in 12 quarters. The position peaked at $520K in Q4 2014. 111 funds tracked by Wall St. Rank hold BBH as of Q2 2023.

Private Trust Company reported no remaining VanEck Biotech ETF position as of Q2 2023 after selling out during the quarter.
Private Trust Company sold 102 VanEck Biotech ETF shares in Q2 2023, an estimated $16.5K.
Private Trust Company first reported a position in VanEck Biotech ETF in Q2 2013 and held it in 12 quarters.
Private Trust Company's VanEck Biotech ETF position peaked at $520K in Q4 2014.
111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2023.

Based on Private Trust Company's 13F filing for Q2 2023, filed 28 Jul 2023.